Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action

Affiliations

• ¹ Department of Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA. rachel.kubiak@merck.com.
• ² Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
• ³ Department of Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ, USA.
• ⁴ Department of Discovery Biology, Merck & Co., Inc., Boston, MA, USA.
• ⁵ Ipsen Bioscience Inc., Cambridge, MA, USA.
• ⁶ Department of Preclinical Development, Merck & Co., Inc., Boston, MA, USA.
• ⁷ Department of Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA.
• ⁸ Synthekine Inc., Menlo Park, CA, USA.
• ⁹ Department of Discovery Biologics, Merck & Co., Inc., Boston, MA, USA.
• ¹⁰ Department of Discovery Oncology, Merck & Co., Inc., Boston, MA, USA.
• ¹¹ Xilio Therapeutics, Waltham, MA, USA.
• ¹² Pandion Therapeutics, Cambridge, MA, USA.
• ¹³ NanoImaging Services, Woburn, MA, USA.